natgillin/translations-raw huggingface dataset:
In children and adolescents weighing 50 kg or greater, a 50 mg/day starting dose is recommended. 
U djece i adolescenata s tjelesnom težinom od 50 kg ili većom, preporučuje se početna doza od 50 mg/dan.
Children (from 4 years of age) and adolescents weighing less than 50 kg The recommended starting dose is 1 mg/kg/day. 
Djeca (od navršene 4 godine) i adolescenti s tjelesnom težinom manjom od 50 kg Preporučena početna doza je 1 mg/kg/dan.
5 ml oral dosing syringe 
5 ml štrcaljka za usta
Briviact 10 mg/ml injection/infusion brivaracetam 
Briviact 10 mg/ml injekcija/infuzija brivaracetam i.v.
Briviact 25 mg film-coated tablets Each 25 mg film-coated tablet contains 94 mg lactose. 
Briviact 25 mg filmom obložene tablete Jedna filmom obložena tableta od 25 mg sadrži 94 mg laktoze.
What Briviact contains The active substance is brivaracetam. 
Sadržaj pakiranja i druge informacije Što Briviact sadrži Djelatna tvar je brivaracetam.
One vial of 5 ml contains 50 mg brivaracetam. 
Jedna bočica od 5 ml sadrži 50 mg brivaracetama.
Valproic acid 
Valproatna kiselina Nema
White to off-white, round film-coated tablets of 6.5 mm in diameter and debossed with ‘u10' on one side. 
Bijele do bjelkaste, okrugle, filmom obložene tablete promjera 6,5 mm, s utisnutom oznakom „u10“ na jednoj strani.
10 ml oral dosing syringe 
10 ml štrcaljka za usta
Seek advice immediately from your doctor if you are pregnant or are planning to become pregnant. 
Ako zatrudnite ili planirate trudnoću, odmah se posavjetujte sa svojim liječnikom.
(corresponding to 1.5 mg/kg/intake) 
(odgovara 1,5 mg/kg/unos)
In rats, there was no effect on fertility with brivaracetam (see section 5.3). 
Brivaracetam nije utjecao na plodnost štakora (vidjeti dio 5.3).
Volume per administration (ml) = [weight (kg) x daily dose (mg/kg/day) ] x 0.05 
Volumen po primjeni (ml) = [tjelesna težina (kg) x dnevna doza (mg/kg/dan) ] x 0,05 Tablica u nastavku navodi primjere volumena oralne otopine po unosu, ovisno o propisanoj dozi i tjelesnoj težini.
- Keep the bottle, the oral syringe, and the leaflet in the carton. 
- Operite štrcaljku za usta samo vodom (slika 13) - Bočicu, štrcaljku za usta i uputu za lijek držite u kutiji.
Briviact 100 mg are green-grey, oval, film-coated tablets of 14.5 mm x 8.1 mm and debossed with ‘u100' on one side. 
Briviact 100 mg su zeleno-sive, ovalne, filmom obložene tablete dimenzija 14,5 mm x 8,1 mm, s utisnutom oznakom „u 100“ na jednoj strani.
Yellow, oval film-coated tablets with dimensions of 11.7 mm x 6.6 mm and debossed with ‘u50' on one side. 
Žute, ovalne, filmom obložene tablete dimenzija 11,7 mm x 6,6 mm, s utisnutom oznakom „u50“ na jednoj strani.
Each ml contains 10 mg brivaracetam. 
Jedan ml sadrži 10 mg brivaracetama.
Brivaracetam is not recommended in end-stage renal disease patients undergoing dialysis due to lack of data. 
Zbog nedostatka podataka, ne preporučuje se primjena brivaracetama u bolesnika u završnom stadiju bubrežne bolesti na dijalizi.
Somnolence and dizziness have been reported in a healthy subject taking a single dose of 1,400 mg of brivaracetam. 
U zdravog ispitanika koji je uzeo jednokratnu dozu brivaracetama od 1400 mg prijavljene su somnolencija i omaglica.
Briviact 25 mg are grey, oval, film-coated tablets of 8.9 mm x 5.0 mm and debossed with ‘u25' on one side. 
Briviact 25 mg su sive, ovalne, filmom obložene tablete dimenzija 8,9 mm x 5,0 mm, s utisnutom oznakom „u 25“ na jednoj strani.
Adults, adolescents and children weighing 50 kg or more - The recommended dose is from 25 mg to 100 mg taken twice a day. 
Odrasli, adolescenti i djeca s tjelesnom težinom od 50 kg ili više - Preporučena doza iznosi od 25 mg do 100 mg uzimana dvaput dnevno.
Concomitant treatment with levetiracetam 
Istodobno liječenje levetiracetamom
Briviact is used together with other medicines for epilepsy. 
Briviact se primjenjuje zajedno s drugim lijekovima za liječenje epilepsije.
(corresponding to 2 mg/kg/intake) 
(odgovara 2 mg/kg/unos)
Nausea, vomiting, constipation 
Poremećaji probavnog sustava često mučnina, povraćanje, konstipacija
(corresponding to 0.5 mg/kg/intake) 
(odgovara 0,5 mg/kg/unos)
Green-grey, oval film-coated tablets with dimensions of 14.5 mm x 8.1 mm and debossed with ‘u100' on one side. 
Zeleno-sive, ovalne, filmom obložene tablete dimenzija 14,5 mm x 8,1 mm, s utisnutom oznakom „u100“ na jednoj strani.
Dose adjustments are recommended for patients with hepatic impairment (see section 
Preporučuje se prilagoditi dozu u bolesnika s oštećenjem jetrene funkcije (vidjeti dio 4.2).
Briviact 50 mg are yellow, oval, film-coated tablets of 11.7 mm x 6.6 mm and debossed with ‘u50' on one side. 
Briviact 50 mg su žute, ovalne, filmom obložene tablete dimenzija 11,7 mm x 6,6 mm, s utisnutom oznakom „u 50“ na jednoj strani.
Briviact 75 mg film-coated tablets Each film-coated tablet contains 75 mg brivaracetam. 
Briviact 75 mg filmom obložene tablete Jedna filmom obložena tableta sadrži 75 mg brivaracetama.
How to store Briviact 6. 
Kako primjenjivati Briviact 4. Moguće nuspojave
Briviact 10 mg/ml solution for injection/infusion brivaracetam 
Briviact 10 mg/ml otopina za injekciju/infuziju brivaracetam
n = 100 n = 99 n = 100 
n = 100
How to store Briviact 
Kako primjenjivati Briviact
Briviact 10 mg/ml oral solution brivaracetam 
Briviact 10 mg/ml oralna otopina brivaracetam
Immune system disorders Uncommon 
Poremećaji imunološkog sustava manje često preosjetljivost tipa
(corresponding to 1 mg/kg/intake) 
(odgovara 1 mg/kg/unos)
Grey, oval film-coated tablets with dimensions of 8.9 mm x 5.0 mm and debossed with ‘u25' on one side. 
Sive, ovalne, filmom obložene tablete dimenzija 8,9 mm x 5,0 mm, s utisnutom oznakom „u25“ na jednoj strani.
In the clinical studies, although the numbers were limited, there was no observed benefit of brivaracetam versus placebo in patients taking levetiracetam concurrently. 
U kliničkim ispitivanjima nije primijećena korist od primjene brivaracetama u odnosu na placebo, u bolesnika koji su istodobno uzimali levetiracetam, iako je njihov broj bio ograničen.
Briviact 75 mg film-coated tablets 
Briviact 75 mg filmom obložene tablete
Citric acid anhydrous (for pH-adjustment) Methyl parahydroxybenzoate (E218) Carmellose sodium 
6.1 Popis pomoćnih tvari natrijev citrat citratna kiselina, bezvodna (za podešavanje pH) metilparahidroksibenzoat (E218)
Briviact 10 mg film-coated tablets Polyvinyl alcohol Titanium dioxide (E171) Macrogol 3350 
Briviact 10 mg filmom obložene tablete poli(vinilni) alkohol titanijev dioksid (E171) makrogol 3350 talk
Briviact 75 mg are purple, oval, film-coated tablets of 13.0 mm x 7.3 mm and debossed with ‘u75' on one side. 
Briviact 75 mg su ljubičaste, ovalne, filmom obložene tablete dimenzija 13,0 mm x 7,3 mm, s utisnutom oznakom „u 75“ na jednoj strani.
(Omitted from cartons of 14 film-coated tablets) 
Za dodatne informacije pročitajte uputu o lijeku. (izostavljeno s kutije za pakiranje od 14 filmom obloženih tableta)
UCB Pharma S.A., Chemin du Foriest, B-1420 Braine-l'Alleud, Belgium. 
UCB Pharma S.A., Chemin du Foriest, B-1420 Braine-l'Alleud, Belgija Za sve informacije o ovom lijeku obratite se lokalnom predstavniku nositelja odobrenja za stavljanje lijeka u promet:
nervous excitement (agitation) - thoughts or attempts of harming or killing yourself: tell your doctor straight away - a decrease in white blood cells (called ‘neutropenia') - shown in blood tests 
Manje česte: mogu se javiti u do 1 na 100 osoba - alergijske reakcije - abnormalne misli i/ili gubitak dodira sa stvarnošću (psihotični poremećaj), agresivno ponašanje, nervozna uzbuđenost (agitacija) - razmišljanje o samoozljeđivanju ili samoubojstvu; odmah to priopćite svojem liječniku - smanjen broj bijelih krvnih stanica (što se naziva „neutropenijom“) - vidljivo u nalazima krvnih pretraga
- Briviact may be diluted before it is injected by your doctor or nurse. 
Prije injekcije, liječnik ili medicinska sestra mogu razrijediti Briviact.
Purple, oval film-coated tablets with dimensions of 13.0 mm x 7.3 mm debossed with ‘u75' on one side. 
Ljubičaste, ovalne, filmom obložene tablete dimenzija 13,0 mm x 7,3 mm, s utisnutom oznakom „u75“ na jednoj strani.
Each film-coated tablet contains 75 mg brivaracetam. 
Jedna filmom obložena tableta sadrži 75 mg brivaracetama.
What Briviact is used for 
Za što se Briviact koristi
For a dose of 1 mg/kg/day 
Za dozu od 1 mg/kg/dan
Briviact 25 mg film-coated tablets Each film-coated tablet contains 25 mg brivaracetam. 
Briviact 25 mg filmom obložene tablete Jedna filmom obložena tableta sadrži 25 mg brivaracetama.
Briviact 75 mg tablets brivaracetam 
Briviact 75 mg tablete brivaracetam
Briviact 25 mg film-coated tablets 
Briviact 25 mg filmom obložene tablete
Each ml of oral solution contains 10 mg brivaracetam. 
Jedan ml oralne otopine sadrži 10 mg brivaracetama.
Briviact 100 mg film-coated tablets Each film-coated tablet contains 100 mg brivaracetam. 
Briviact 100 mg filmom obložene tablete Jedna filmom obložena tableta sadrži 100 mg brivaracetama.
What Briviact looks like and contents of the pack Briviact 10 mg are white to off-white, round, film-coated tablets of 6.5 mm in diameter and debossed with ‘u10' on one side. 
Briviact 10 mg su bijele do bjelkaste, okrugle, filmom obložene tablete promjera 6,5 mm, s utisnutom oznakom „u 10“ na jednoj strani.
Briviact 100 mg tablets brivaracetam 
Briviact 100 mg tablete brivaracetam
Briviact 10 mg film-coated tablets Each film-coated tablet contains 10 mg brivaracetam. 
Briviact 10 mg filmom obložene tablete Jedna filmom obložena tableta sadrži 10 mg brivaracetama.
Briviact 100 mg film-coated tablets 
Briviact 100 mg filmom obložene tablete
Each film-coated tablet contains 100 mg brivaracetam. 
Jedna filmom obložena tableta sadrži 100 mg brivaracetama.
Each film-coated tablet contains 25 mg brivaracetam. 
Jedna filmom obložena tableta sadrži 25 mg brivaracetama.
For a dose of 4 mg/kg/day 
Za dozu od 4 mg/kg/dan
Briviact 10 mg tablets brivaracetam 
Briviact 10 mg tablete brivaracetam
Briviact 10 mg film-coated tablets 
Briviact 10 mg filmom obložene tablete
Each film-coated tablet contains 10 mg brivaracetam. 
Jedna filmom obložena tableta sadrži 10 mg brivaracetama.
Briviact 50 mg film-coated tablets Each film-coated tablet contains 50 mg brivaracetam. 
Briviact 50 mg filmom obložene tablete Jedna filmom obložena tableta sadrži 50 mg brivaracetama.
Briviact 25 mg tablets brivaracetam 
Briviact 25 mg tablete brivaracetam
Briviact 50 mg film-coated tablets 
Briviact 50 mg filmom obložene tablete
- If you weigh 20 kg or more, your doctor will recommend the use of the 5 ml oral syringe or the 
- Ako je Vaša tjelesna težina 20 kg ili više, trebate koristiti štrcaljku za usta od 5 ml ili od 10 ml priloženu u kutiju, kako biste osigurali točno doziranje.
Only clear solution free from particles and discoloration should be used. 
Smije se primijeniti samo bistra otopina koja ne sadrži vidljive čestice i koja nije promijenila boju.
Strong enzyme inducing AEDs 
Antiepileptici koji su snažni enzimski induktori
Depression, anxiety, insomnia, irritability 
Psihijatrijski poremećaji često depresija, anksioznost, nesanica, razdražljivost manje često suicidalne ideje, psihotični poremećaj, agresivnost, agitacija
For a dose of 3 mg/kg/day 
Za dozu od 3 mg/kg/dan
- As an adult, adolescent or child weighing 50 kg or more, the maximum dose you will take is 
- kao odrasla osoba, adolescent ili dijete s tjelesnom težinom od 50 kg ili više, najveća doza koju ćete dobiti bit će 75 mg dvaput dnevno.
For a dose of 2 mg/kg/day 
Za dozu od 2 mg/kg/dan
Briviact 50 mg tablets brivaracetam 
Briviact 50 mg tablete brivaracetam
Each film-coated tablet contains 50 mg brivaracetam. 
Jedna filmom obložena tableta sadrži 50 mg brivaracetama.
Briviact 75 mg film-coated tablets brivaracetam 
Briviact 75 mg filmom obložene tablete brivaracetam
Children (from 4 years of age) and adolescents weighing 50 kg or more 
Djeca (≥4 godine) i adolescenti ≥50 kg
0.05 ml/kg/intake 
0,05 ml/kg/unos
EU/1/15/1073/017 14 film-coated tablets EU/1/15/1073/018 56 film-coated tablets EU/1/15/1073/019 100 x 1 film-coated tablet EU/1/15/1073/027 14 x 1 film-coated tablet 
EU/1/15/1073/017 14 filmom obloženih tableta EU/1/15/1073/018 56 filmom obloženih tableta EU/1/15/1073/019 100 x 1 filmom obložena tableta EU/1/15/1073/027 14 x 1 filmom obložena tableta
0.5 mg/kg = 0.05 ml/kg 
Tjelesna težina 0,5 mg/kg = 0,05 ml/kg
Briviact 100 mg film-coated tablets brivaracetam 
Briviact 100 mg filmom obložene tablete brivaracetam
Briviact 10 mg film-coated tablets brivaracetam 
Briviact 10 mg filmom obložene tablete brivaracetam
Briviact 25 mg film-coated tablets brivaracetam 
Briviact 25 mg filmom obložene tablete brivaracetam
EU/1/15/1073/013 14 film-coated tablets EU/1/15/1073/014 56 film-coated tablets EU/1/15/1073/015 100 x 1 film-coated tablet EU/1/15/1073/026 14 x 1 film-coated tablet 
EU/1/15/1073/013 14 filmom obloženih tableta EU/1/15/1073/014 56 filmom obloženih tableta EU/1/15/1073/015 100 x 1 filmom obložena tableta EU/1/15/1073/026 14 x 1 filmom obložena tableta
EU/1/15/1073/004 168 (3 packs of 56) film-coated tablets 
EU/1/15/1073/004 168 (3 pakiranja od 56) filmom obloženih tableta
Croscarmellose Sodium, Lactose monohydrate Betadex 
6.1 Popis pomoćnih tvari Jezgra karmelozanatrij, umrežena laktoza hidrat betadeks laktoza, bezvodna magnezijev stearat
Briviact 50 mg film-coated tablets brivaracetam 
Briviact 50 mg filmom obložene tablete brivaracetam
- 75 mg film-coated tablets: polyvinyl alcohol, titanium dioxide (E171), macrogol 3350, talc, iron oxide yellow (E172), iron oxide red (E172), iron oxide black (E172). 
Briviact 75 mg filmom obložene tablete poli(vinilni) alkohol titanijev dioksid (E171) makrogol 3350 talk željezov oksid, žuti (E172) željezov oksid, crveni (E172) željezov oksid, crni (E172)
Briviact 10 mg/ml oral solution 
Briviact 10 mg/ml oralna otopina
EU/1/15/1073/008 168 (3 packs of 56) film-coated tablets 
EU/1/15/1073/008 168 (3 pakiranja od 56) filmom obloženih tableta
EU/1/15/1073/009 14 film-coated tablets EU/1/15/1073/010 56 film-coated tablets EU/1/15/1073/011 100 x 1 film-coated tablet EU/1/15/1073/025 14 x 1 film-coated tablet 
EU/1/15/1073/009 14 filmom obloženih tableta EU/1/15/1073/010 56 filmom obloženih tableta EU/1/15/1073/011 100 x 1 filmom obložena tableta EU/1/15/1073/025 14 x 1 filmom obložena tableta
EU/1/15/1073/020 168 (3 packs of 56) film-coated tablets 
EU/1/15/1073/020 168 (3 pakiranja od 56) filmom obloženih tableta
EU/1/15/1073/005 14 film-coated tablets EU/1/15/1073/006 56 film-coated tablets EU/1/15/1073/007 100 x 1 film-coated tablet EU/1/15/1073/024 14 x 1 film-coated tablet 
EU/1/15/1073/005 14 filmom obloženih tableta EU/1/15/1073/006 56 filmom obloženih tableta EU/1/15/1073/007 100 x 1 filmom obložena tableta EU/1/15/1073/024 14 x 1 filmom obložena tableta
Two oral syringes will be provided in the carton. 
Upute za uporabu za bolesnike ili njegovatelje: Dvije štrcaljke za usta bit će priložene u kutiju.
EU/1/15/1073/001 14 film-coated tablets EU/1/15/1073/002 56 film-coated tablets EU/1/15/1073/003 100 x 1 film-coated tablet EU/1/15/1073/023 14 x 1 film-coated tablet 
EU/1/15/1073/001 14 filmom obloženih tableta EU/1/15/1073/002 56 filmom obloženih tableta EU/1/15/1073/003 100 x 1 filmom obložena tableta EU/1/15/1073/023 14 x 1 filmom obložena tableta
EU/1/15/1073/012 168 (3 packs of 56) film-coated tablets 
EU/1/15/1073/012 168 (3 pakiranja od 56) filmom obloženih tableta
- 100 mg film-coated tablets: polyvinyl alcohol, titanium dioxide (E171), macrogol 3350, talc, iron oxide yellow (E172), iron oxide black (E172). 
Briviact 100 mg filmom obložene tablete poli(vinilni) alkohol titanijev dioksid (E171) makrogol 3350 talk željezov oksid, žuti (E172) željezov oksid, crni (E172)
EU/1/15/1073/016 168 (3 packs of 56) film-coated tablets 
EU/1/15/1073/016 168 (3 pakiranja od 56) filmom obloženih tableta
Treatment with levetiracetam 
Liječenje levetiracetamom
Coating 
Dojenje
0.1 ml/kg/intake 
0,1 ml/kg/unos
The table below provides examples of volumes of oral solution per intake depending on prescribed dose and body weight. 
Pedijatrijska populacija Liječnik treba propisati najprimjereniju formulaciju i jačinu u skladu s tjelesnom težinom i dozom.
Clobazam 
Klobazam
- 50 mg film-coated tablets: polyvinyl alcohol, titanium dioxide (E171), macrogol 3350, talc, iron oxide yellow (E172), iron oxide red (E172). 
Briviact 50 mg filmom obložene tablete poli(vinilni) alkohol titanijev dioksid (E171) makrogol 3350 talk željezov oksid, žuti (E172) željezov oksid, crveni (E172)
- 25 mg film-coated tablets: polyvinyl alcohol, titanium dioxide (E171), macrogol 3350, talc, iron oxide yellow (E172), iron oxide black (E172). 
Briviact 25 mg filmom obložene tablete poli(vinilni) alkohol titanijev dioksid (E171) makrogol 3350 talk željezov oksid, žuti (E172) željezov oksid, crni (E172)
Upper respiratory tract infections, cough 
Poremećaji dišnog sustava, prsišta i sredoprsja često infekcije gornjih dišnih putova, kašalj
5260 Odense S, Denmark 
5260 Odense S, Danska
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. 
Pažljivo pročitajte cijelu uputu prije nego počnete ovaj uzimati ovaj lijek jer sadrži Vama važne podatke.
Always take this medicine exactly as your doctor or pharmacist has told you. 
Uvijek uzmite ovaj lijek točno onako kako su Vam rekli Vas liječnik ili ljekarnik.
If you take more Grepid than you should 
Ako uzmete više Grepida nego što ste trebali
Other medicines and Grepid 
Drugi lijekovi i Grepid
While you are taking Grepid: 
Dok uzimate Grepid:
OTHER SPECIAL WARNING(S), IF NECESSARY 
DRUG O(A) POSEBNO(A) UPOZORENJE(A), AKO JE POTREBNO
• if you have had an allergy or reaction to any medicine used to treat your disease 
• Ako ste imali alergiju ili reakciju na bilo koji lijek koji ste koristili za liječenje Vaše bolesti.
What Grepid is and what it is used for 
Što je Grepid i za što se koristi
Some other medicines may influence the use of Grepid or vice versa. 
Neki lijekovi mogu utjecati na djelovanje Grepida i obratno.
No special storage conditions (for all aluminium blisters) 
Nema posebnih uvjeta čuvanja (za aluminijske blistere)
You should take Grepid for as long as your doctor continues to prescribe it. 
Grepid trebate uzimati sve dok Vam ga liječnik propisuje.
Date of first authorisation: 28 July 2009 Date of latest renewal: 11 April 2014 
Datum posljednje obnove: 11. travanj 2014.
- if you are allergic to clopidogrel or any of the other ingredients of this medicine (listed in section 6). 
• ako ste alergični na klopidogrel ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.)
EU/1/09/535/001 14 Film-coated tablets blister (PVC/PE/PVDC/alu) EU/1/09/535/002 28 Film-coated tablets blister (PVC/PE/PVDC/alu) EU/1/09/535/003 30 Film-coated tablets blister (PVC/PE/PVDC/alu) EU/1/09/535/004 50 Film-coated tablets blister (PVC/PE/PVDC/alu) EU/1/09/535/005 84 Film-coated tablets blister (PVC/PE/PVDC/alu) EU/1/09/535/006 90 Film-coated tablets blister (PVC/PE/PVDC/alu) EU/1/09/535/007 100 Film-coated tablets blister (PVC/PE/PVDC/alu) EU/1/09/535/008 14 Film-coated tablets blister (alu/alu) EU/1/09/535/009 28 Film-coated tablets blister (alu/alu) EU/1/09/535/010 30 Film-coated tablets blister (alu/alu) EU/1/09/535/011 50 Film-coated tablets blister (alu/alu) EU/1/09/535/012 84 Film-coated tablets blister (alu/alu) EU/1/09/535/013 90 Film-coated tablets blister (alu/alu) EU/1/09/535/014 100 Film-coated tablets blister (alu/alu) EU/1/09/535/015 10 Film-coated tablets blister (PVC/PE/PVDC/alu) EU/1/09/535/016 28 Film-coated tablets blister (PVC/PE/PVDC/alu), calendar 
EU/1/09/535/001 14 Filmom obloženih tableta blister (PVC/PE/PVDC/Al) EU/1/09/535/002 28 Filmom obloženih tableta blister (PVC/PE/PVDC/Al) EU/1/09/535/003 30 Filmom obloženih tableta blister (PVC/PE/PVDC/Al) EU/1/09/535/004 50 Filmom obloženih tableta blister (PVC/PE/PVDC/Al) EU/1/09/535/005 84 Filmom obloženih tableta blister (PVC/PE/PVDC/Al) EU/1/09/535/006 90 Filmom obloženih tableta blister (PVC/PE/PVDC/Al) EU/1/09/535/007 100 Filmom obloženih tableta blister (PVC/PE/PVDC/Al) EU/1/09/535/008 14 Filmom obloženih tableta blister (Al/Al) EU/1/09/535/009 28 Filmom obloženih tableta blister (Al/Al) EU/1/09/535/010 30 Filmom obloženih tableta blister (Al/Al) EU/1/09/535/011 50 Filmom obloženih tableta blister (Al/Al) EU/1/09/535/012 84 Filmom obloženih tableta blister (Al/Al) EU/1/09/535/013 90 Filmom obloženih tableta blister (Al/Al) EU/1/09/535/014 100 Filmom obloženih tableta blister (Al/Al) EU/1/09/535/015 10 Filmom obloženih tableta blister (PVC/PE/PVDC/Al) EU/1/09/535/016 28 Filmom obloženih tableta blister (PVC/PE/PVDC/Al), kalendarski
What you need to know before you take Grepid 
Što morate znati prije nego počnete uzimati Grepid
What Grepid is and what it is used for What you need to know before you take Grepid How to take Grepid 
Što se nalazi u ovoj uputi Što je Grepid i za što se koristi Što morate znati prije nego počnete uzimati Grepid Kako uzimati Grepid
Their frequency is defined using the following conventions: common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000), not known (cannot be estimated from the available data). 
Njihova je učestalost definirana na sljedeći način: česte (≥1/100, <1/10), manje česte (≥1/1000, <1/100), rijetke (≥1/10 000, <1/1000), vrlo rijetke (<1/10 000), nepoznato (ne može se procijeniti iz dostupnih podataka).
This leaflet was last revised in <Month YYYY>. 
Ova uputa je zadnji puta revidirana u<mjesec GGGG>:
Grepid contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products. 
Grepid sadrži klopidogrel i pripada skupini lijekova koji se nazivaju antitrombocitni lijekovi.
An occasional use of acetylsalicylic acid (not more than 1,000 mg in 24 hour period) should generally not cause a problem, but prolonged use in other circumstances should be discussed with your doctor. 
Povremeno uzimanje acetilsalicilatne kiseline (ne više od 1000 mg u 24 sata) općenito ne izaziva probleme, ali o produljenom uzimanju u drugim okolnostima morate razgovarati s liječnikom.
During non-clinical studies in rat and baboon, the most frequently observed effects were liver changes. 
Tijekom nekliničkih ispitivanja na štakorima i babunima najčešće zabilježeni učinci bile su promjene na jetri.
- if you suffer from severe liver disease. 
• ako patite od teške bolesti jetre.
What Grepid looks like and contents of the pack 
Kako Grepid izgleda i sadržaj pakiranja
You should have been told that ‘oral anticoagulants' are more effective than acetylsalicylic acid or the combined use of Grepid and acetylsalicylic acid for this condition. 
Trebalo Vam je biti rečeno da su za ovo stanje ''oralni antikoagulansi'' učinkovitiji od acetilsalicilatne kiseline ili kombinirane primjene Grepida i acetilsalicilatne kiseline.
What Grepid contains 
Što Grepid sadrži
As a precautionary measure, breast-feeding should not be continued during treatment with Grepid. 
Kao mjera opreza, treba prestati s dojenjem za vrijeme liječenja Grepidom.
If you stop taking Grepid 
Ako prestanete uzimati Grepid
Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu/ 
Detaljnije informacije o ovom lijeku dostupne su na internetskoj stranici Europske agencije za lijekove: http://www.ema.europa.eu/.
Your doctor should have prescribed Grepid plus acetylsalicylic acid if you cannot take ‘oral anticoagulants' and you do not have a risk of major bleeding. 
Liječnik Vam treba propisati Grepid i acetilsalicilatnu kiselinu ako ne možete uzimati oralne antikoagulanse te nemate rizik od velikog krvarenja.
10 film-coated tablets 14 film-coated tablets 28 film-coated tablets 30 film-coated tablets 50 film-coated tablets 84 film-coated tablets 90 film-coated tablets 100 film-coated tablets 
10 filmom obloženih tableta 14 filmom obloženih tableta 28 filmom obloženih tableta 30 filmom obložene tablete 50 filmom obloženih tableta 84 filmom obloženih tableta 90 filmom obloženih tableta 100 filmom obloženih tableta